Format

Send to

Choose Destination
J Nutr. 2018 Jun 1;148(suppl_1):1001S-1067S. doi: 10.1093/jn/nxx036.

Biomarkers of Nutrition for Development (BOND)-Iron Review.

Author information

1
National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.
2
Division of Neonatology, Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis, MN.
3
Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY.
4
Department of Nutrition, Norwich Medical School, Norwich Research Park, University of East Anglia, Norwich NR4 7JT, UK.
5
Institute of Food, Nutrition and Health, Swiss Federal Institute of Technology, Zurich, Switzerland.
6
Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen AB21 9SB, UK.
7
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH).

Abstract

This is the fifth in the series of reviews developed as part of the Biomarkers of Nutrition for Development (BOND) program. The BOND Iron Expert Panel (I-EP) reviewed the extant knowledge regarding iron biology, public health implications, and the relative usefulness of currently available biomarkers of iron status from deficiency to overload. Approaches to assessing intake, including bioavailability, are also covered. The report also covers technical and laboratory considerations for the use of available biomarkers of iron status, and concludes with a description of research priorities along with a brief discussion of new biomarkers with potential for use across the spectrum of activities related to the study of iron in human health.The I-EP concluded that current iron biomarkers are reliable for accurately assessing many aspects of iron nutrition. However, a clear distinction is made between the relative strengths of biomarkers to assess hematological consequences of iron deficiency versus other putative functional outcomes, particularly the relationship between maternal and fetal iron status during pregnancy, birth outcomes, and infant cognitive, motor and emotional development. The I-EP also highlighted the importance of considering the confounding effects of inflammation and infection on the interpretation of iron biomarker results, as well as the impact of life stage. Finally, alternative approaches to the evaluation of the risk for nutritional iron overload at the population level are presented, because the currently designated upper limits for the biomarker generally employed (serum ferritin) may not differentiate between true iron overload and the effects of subclinical inflammation.

PMID:
29878148
PMCID:
PMC6297556
DOI:
10.1093/jn/nxx036
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center